Control Bionics (ASX: CBL) registers NeuroStrip with US FDA as commercial execution becomes the next test
Read More Pharma Industry News Suven Life Sciences set to begin samelisant phase 2 trial in narcolepsy Suven Life Sciences has announced the successful completion of enrollment for its phase-2 proof-of-concept (PoC) clinical study to… byPallavi MadhirajuJune 3, 2023